[Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[H. Con. Res. 405 Introduced in House (IH)]






108th CONGRESS
  2d Session
H. CON. RES. 405

 Expressing the sense of Congress with respect to the need to provide 
   prostate cancer patients with meaningful access to information on 
               treatment options, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             April 2, 2004

Mr. Deal of Georgia (for himself, Mr. Towns, Mr. Burr, Mr. Norwood, Mr. 
Rahall, Mr. Wamp, and Mr. Whitfield) submitted the following concurrent 
 resolution; which was referred to the Committee on Energy and Commerce

_______________________________________________________________________

                         CONCURRENT RESOLUTION


 
 Expressing the sense of Congress with respect to the need to provide 
   prostate cancer patients with meaningful access to information on 
               treatment options, and for other purposes.

Whereas in 2004, it is estimated that approximately 230,000 new cases of 
        prostate cancer will be diagnosed in the United States, and nearly 
        30,000 men in the United States will die from prostate cancer;
Whereas prostate cancer is the second leading cause of cancer death in men in 
        the United States;
Whereas over $4,700,000,000 is spent annually in the United States in direct 
        treatment costs for prostate cancer;
Whereas African American men are diagnosed with and die from prostate cancer 
        more frequently than men of other ethnic backgrounds;
Whereas increased education among health care providers and patients regarding 
        the need for prostate cancer screening tests has resulted in the 
        diagnosis of approximately 86 percent of prostate cancer patients before 
        the cancerous cells have spread appreciably beyond the prostate gland, 
        thereby enhancing the odds of successful treatment;
Whereas the potential complication rates for significant side effects vary among 
        the most common forms of treatment for prostate cancer;
Whereas prostate cancer often strikes elderly people in the United States, 
        highlighting the importance of balancing the potential benefits and 
        risks of various treatments on an individual basis; and
Whereas Congress as an whole, and Members of Congress as individuals, are in 
        unique positions to support the fight against prostate cancer, to help 
        raise public awareness about the need to make screening tests available 
        to all people at risk for prostate cancer, and to provide prostate 
        cancer patients with adequate information to assess the relative 
        benefits and risks of treatment options: Now, therefore, be it
    Resolved by the House of Representatives (the Senate concurring), 
That it is the sense of the Congress that--
            (1) national and community organizations and health care 
        providers have played a commendable role in supplying 
        information concerning the importance of screening for prostate 
        cancer and the treatment options for patients with prostate 
        cancer; and
            (2) the Federal Government and the States have a moral 
        responsibility to ensure that health care providers supply 
        prostate cancer patients with appropriate information and any 
        other tools necessary for prostate cancer patients to receive 
        readily understandable descriptions of the advantages, 
        disadvantages, benefits, and risks of all medically efficacious 
        treatments for prostate cancer, including brachytherapy, 
        hormonal treatments, external beam radiation, chemotherapy, 
        surgery, and watchful waiting.
                                 <all>